Key result
Delaying left atrial myxoma resection until COVID-19 resolution allows successful surgery without complications.
Why the study?
In the COVID-19 pandemic era, concurrent COVID-19 infection and mitigation protocols complicate management decisions for primary cardiac tumors such as myxomas.
Case Report (n=1)
Delaying surgical resection of a cardiac myxoma until resolution of a concurrent COVID-19 infection can be a safe and effective management strategy.
Answers are grounded in this paper and cite their sources.
May support delaying myxoma resection until COVID-19 resolution; hypothesis-generating and requires confirmation before broader adoption.
Primary cardiac tumors (PCTs) are extremely rare entities. More than half of PCTs are benign, with myxoma being the most common tumor. Generally, simple tumor resection is the treatment of choice for benign PCTs since it has promising results that yield low complication and recurrence rates. However, in the COVID-19 pandemic era, the mitigation protocols and/or concurrent COVID-19 infection should be taken into account in patient management for the best overall outcome. To our knowledge, this is the first case report of a patient with a left atrial myxoma and systemic embolism complication in the form of an ischemic stroke, with a concurrent confirmed COVID-19 delta variant infection.
No takes yet. Share an insight, caveat, or question.
Nasution et al. (2022) conducted a case report in Left atrial myxoma with concurrent Delta variant COVID-19 infection (n=1). Surgical tumor resection was evaluated on Patient recovery and tumor evacuation. Surgical resection of a left atrial myxoma was successfully performed without complications after delaying the procedure until the resolution of a concurrent Delta variant COVID-19 infection.
Synapse has enriched 10 related papers. Consider them for comparative context: